{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T01:44:34Z","timestamp":1784684674201,"version":"3.55.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.rdc.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T03:30:16Z","timestamp":1510716616000},"page":"15-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Gastrointestinal and Hepatic Disease in Systemic Sclerosis"],"prefix":"10.1016","volume":"44","author":[{"given":"Tracy M.","family":"Frech","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Mar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.berh.2016.04.004","article-title":"Systemic sclerosis: the need for structured care","volume":"30","author":"Morrisroe","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2017.09.002_bib2","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib3","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1097\/01.bor.0000434668.32150.e5","article-title":"Measuring response in the gastrointestinal tract in systemic sclerosis","volume":"25","author":"Khanna","year":"2013","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 3","key":"10.1016\/j.rdc.2017.09.002_bib4","first-page":"iii36","article-title":"Gastrointestinal complications: the most frequent internal complications of systemic sclerosis","volume":"48","author":"Forbes","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.002_bib5","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","article-title":"Incidence and prevalence of systemic sclerosis: a systematic literature review","volume":"37","author":"Chifflot","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.002_bib6","first-page":"359","article-title":"Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis","volume":"34","author":"Malcarne","year":"2007","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2017.09.002_bib7","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1002\/1529-0131(200011)43:11<2437::AID-ANR10>3.0.CO;2-U","article-title":"Severe organ involvement in systemic sclerosis with diffuse scleroderma","volume":"43","author":"Steen","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2017.09.002_bib8","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/apt.13963","article-title":"Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis","volume":"45","author":"Kumar","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.7326\/0003-4819-140-1-200401060-00010","article-title":"Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis","volume":"140","author":"Jimenez","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rdc.2017.09.002_bib10","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","article-title":"Pathogenesis of systemic sclerosis","volume":"6","author":"Pattanaik","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0889-857X(21)01046-2","article-title":"Animal models of fibrosis","volume":"16","author":"Bocchieri","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"10.1016\/j.rdc.2017.09.002_bib12","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/rheumatology\/kes191","article-title":"Gut fibrosis with altered colonic contractility in a mouse model of scleroderma","volume":"51","author":"Thoua","year":"2012","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.rdc.2017.09.002_bib13","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1002\/art.23806","article-title":"Endothelial\/lymphocyte activation leads to prominent CD4+ T\u00a0cell infiltration in the gastric mucosa of patients with systemic sclerosis","volume":"58","author":"Manetti","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.002_bib14","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00281-015-0511-7","article-title":"Cytokines in the immunopathology of systemic sclerosis","volume":"37","author":"Raja","year":"2015","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.002_bib15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1053\/gast.2002.36057","article-title":"Antibody-mediated gastrointestinal dysmotility in scleroderma","volume":"123","author":"Goldblatt","year":"2002","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib16","doi-asserted-by":"crossref","first-page":"G1206","DOI":"10.1152\/ajpgi.00286.2009","article-title":"Immunoglobulins from scleroderma patients inhibit the muscarinic receptor activation in internal anal sphincter smooth muscle cells","volume":"297","author":"Singh","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"11","key":"10.1016\/j.rdc.2017.09.002_bib17","doi-asserted-by":"crossref","first-page":"G1052","DOI":"10.1152\/ajpgi.00034.2016","article-title":"Role of muscarinic-3 receptor antibody in systemic sclerosis: correlation with disease duration and effects of IVIG","volume":"310","author":"Kumar","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bdj.2016.678","article-title":"Orofacial manifestations of systemic sclerosis","volume":"221","author":"Veale","year":"2016","journal-title":"Br Dent J"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/RHU.0000000000000339","article-title":"Sublingual abnormalities in systemic sclerosis","volume":"22","author":"Frech","year":"2016","journal-title":"J\u00a0Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.002_bib20","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/odi.12507","article-title":"The spectrum of orofacial manifestations in systemic sclerosis: a challenging management","volume":"23","author":"Jung","year":"2017","journal-title":"Oral Dis"},{"issue":"6 Suppl 86","key":"10.1016\/j.rdc.2017.09.002_bib21","first-page":"S-214","article-title":"Consensus best practice pathway of the UK scleroderma study group: gastrointestinal manifestations of systemic sclerosis","volume":"32","author":"Hansi","year":"2014","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib22","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00296-010-1595-y","article-title":"Early endoscopy in systemic sclerosis without gastrointestinal symptoms","volume":"32","author":"Thonhofer","year":"2012","journal-title":"Rheumatol Int"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.002_bib23","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.cgh.2016.03.039","article-title":"Loss of peristaltic reserve, determined by multiple rapid swallows, is the most frequent esophageal motility abnormality in patients with systemic sclerosis","volume":"14","author":"Carlson","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semarthrit.2016.02.004","article-title":"Esophageal dilatation and interstitial lung disease in systemic sclerosis: a cross-sectional study","volume":"46","author":"Richardson","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.002_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2008.03739.x","article-title":"Watermelon stomach in systemic sclerosis: its incidence and management","volume":"28","author":"Marie","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.002_bib26","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3899\/jrheum.090600","article-title":"Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors","volume":"37","author":"Ingraham","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib27","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2036.2006.02804.x","article-title":"Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma)","volume":"23","author":"Sallam","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.002_bib28","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/rheumatology\/kep226","article-title":"Small intestinal bacterial overgrowth in systemic sclerosis","volume":"48","author":"Marie","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib29","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/rheumatology\/kel203","article-title":"Outcome of small-bowel motor impairment in systemic sclerosis\u2013a prospective manometric 5-yr follow-up","volume":"46","author":"Marie","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.rdc.2017.09.002_bib30","first-page":"2474515","article-title":"Pneumatosis cystoides intestinalis in patients with systemic sclerosis: a case report and review of 39 Japanese cases","volume":"2016","author":"Kaneko","year":"2016","journal-title":"Case Rep Gastrointest Med"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.002_bib31","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.3899\/jrheum.090340","article-title":"Primary biliary cirrhosis (PBC), PBC autoantibodies, and hepatic parameter abnormalities in a large population of systemic sclerosis patients","volume":"36","author":"Assassi","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.002_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/gut.2005.075002","article-title":"Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis","volume":"55","author":"Rigamonti","year":"2006","journal-title":"Gut"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/BF02238554","article-title":"Nodular regenerative hyperplasia of the liver in a patient with systemic sclerosis","volume":"15","author":"Kaburaki","year":"1996","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.002_bib34","first-page":"211","article-title":"Development of systemic sclerosis in patients with autoimmune hepatitis: an emerging overlap syndrome","volume":"9","author":"Assandri","year":"2016","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10067-010-1586-0","article-title":"Liver autoantibodies in patients with scleroderma","volume":"30","author":"Skare","year":"2011","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/MCG.0b013e318042d625","article-title":"Gastric and enteric involvement in progressive systemic sclerosis","volume":"42","author":"Ebert","year":"2008","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.002_bib37","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/BF01308615","article-title":"Anorectal dysfunction and delayed colonic transit in patients with progressive systemic sclerosis","volume":"38","author":"Basilisco","year":"1993","journal-title":"Dig Dis Sci"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.002_bib38","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3109\/00365521.2011.603158","article-title":"Gastrointestinal transit in patients with systemic sclerosis","volume":"46","author":"Fynne","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib39","first-page":"62","article-title":"Rectal prolapse in scleroderma: case report and review of the colonic complications of scleroderma","volume":"28","author":"D'Angelo","year":"1985","journal-title":"Can J Surg"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.002_bib40","first-page":"581","article-title":"Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues","volume":"56","author":"Richard","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.002_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/ajg.2011.399","article-title":"Fecal incontinence in systemic sclerosis is secondary to neuropathy","volume":"107","author":"Thoua","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.002_bib42","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/DCR.0b013e31819a5d59","article-title":"The internal anal sphincter in systemic sclerosis","volume":"52","author":"Koh","year":"2009","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib43","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1023\/B:DDAS.0000034569.85066.69","article-title":"Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence","volume":"49","author":"Heyt","year":"2004","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib44","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1259\/dmfr\/14556986","article-title":"Mandibular resorption in progressive systemic sclerosis: a report of three cases","volume":"34","author":"Auluck","year":"2005","journal-title":"Dentomaxillofac Radiol"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.002_bib45","first-page":"637","article-title":"Increased incidence of carcinoma of the tongue in patients with systemic sclerosis","volume":"32","author":"Derk","year":"2005","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib46","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1136\/ard.40.6.612","article-title":"Pharyngo-oesophageal dysphagia in systemic sclerosis","volume":"40","author":"Rajapakse","year":"1981","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2017.09.002_bib47","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1111\/imj.13243","article-title":"Pharyngoesophageal dysphagia: an under recognised, potentially fatal, but very treatable feature of systemic sclerosis","volume":"46","author":"Rajapakse","year":"2016","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib48","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s40674-014-0005-0","article-title":"Management of gastrointestinal involvement in scleroderma","volume":"1","author":"Nagaraja","year":"2015","journal-title":"Curr Treatm Opt Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.002_bib49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/rheumatology\/35.3.298","article-title":"Pancreatic function in systemic sclerosis","volume":"35","author":"Shawis","year":"1996","journal-title":"Br J Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib50","doi-asserted-by":"crossref","first-page":"462","DOI":"10.3109\/03009742.2011.579575","article-title":"Faecal incontinence in patients with systemic sclerosis: is an impaired internal anal sphincter the only cause?","volume":"40","author":"Fynne","year":"2011","journal-title":"Scand J Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2017.09.002_bib51","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.3899\/jrheum.090694","article-title":"Malnutrition is common in systemic sclerosis: results from the Canadian Scleroderma Research Group database","volume":"36","author":"Baron","year":"2009","journal-title":"J\u00a0Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2017.09.002_bib52","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1136\/ard.2009.123273","article-title":"Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis","volume":"69","author":"Krause","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"2 Suppl 58","key":"10.1016\/j.rdc.2017.09.002_bib53","first-page":"S42","article-title":"Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel","volume":"28","author":"Baron","year":"2010","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.clnu.2012.06.005","article-title":"Nutritional status and gastrointestinal symptoms in systemic sclerosis patients","volume":"32","author":"Murtaugh","year":"2013","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.002_bib55","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1080\/07315724.2010.10719828","article-title":"Is serum albumin a marker of malnutrition in chronic disease? The scleroderma paradigm","volume":"29","author":"Baron","year":"2010","journal-title":"J\u00a0Am Coll Nutr"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.002_bib56","first-page":"115","article-title":"High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity","volume":"34 Suppl 100","author":"Raja","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3899\/jrheum.090697","article-title":"Telangiectases in scleroderma: a potential clinical marker of pulmonary arterial hypertension","volume":"37","author":"Shah","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.002_bib58","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/rheumatology\/kev393","article-title":"Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample","volume":"55","author":"Valenzuela","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.002_bib59","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/rheumatology\/kew322","article-title":"Understanding empirical therapeutics in systemic sclerosis gastrointestinal tract disease","volume":"56","author":"Frech","year":"2017","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.rdc.2017.09.002_bib60","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1038\/ajg.2014.237","article-title":"Development of the NIH patient-reported outcomes measurement information system (PROMIS) gastrointestinal symptom scales","volume":"109","author":"Spiegel","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.002_bib61","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/acr.20480","article-title":"Recommendations for the care of oral involvement in patients with systemic sclerosis","volume":"63","author":"Alantar","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib62","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3109\/09638288.2011.587589","article-title":"Effect of orofacial exercises on oral aperture in adults with systemic sclerosis","volume":"34","author":"Yuen","year":"2012","journal-title":"Disabil Rehabil"},{"issue":"2 Suppl 65","key":"10.1016\/j.rdc.2017.09.002_bib63","first-page":"S26","article-title":"Effect of a multi-faceted intervention on gingival health among adults with systemic sclerosis","volume":"29","author":"Yuen","year":"2011","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2017.09.002_bib64","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib65","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1053\/j.gastro.2013.09.046","article-title":"A\u00a0diet low in FODMAPs reduces symptoms of irritable bowel syndrome","volume":"146","author":"Halmos","year":"2014","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.rdc.2017.09.002_bib66","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/apt.12496","article-title":"Review article: the assessment and management of chronic severe gastrointestinal dysmotility in adults","volume":"38","author":"Paine","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.002_bib67","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1159\/000445226","article-title":"Functional dyspepsia and gastroparesis","volume":"34","author":"Camilleri","year":"2016","journal-title":"Dig Dis"},{"issue":"7","key":"10.1016\/j.rdc.2017.09.002_bib68","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.cgh.2008.02.065","article-title":"A\u00a0systematic review of the efficacy of domperidone for the treatment of diabetic gastroparesis","volume":"6","author":"Sugumar","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"10.1016\/j.rdc.2017.09.002_bib69","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2169\/internalmedicine.33.407","article-title":"Effect of H2-receptor antagonists cimetidine and famotidine on interdigestive gastric motor activity and lower esophageal sphincter pressure in progressive systemic sclerosis","volume":"33","author":"Horikoshi","year":"1994","journal-title":"Intern Med"},{"issue":"2","key":"10.1016\/j.rdc.2017.09.002_bib70","first-page":"70","article-title":"Successful treatment of severe reflux esophagitis with erythromycin in a patient with progressive systemic sclerosis and proximal gastrectomy","volume":"31","author":"Hara","year":"2006","journal-title":"Tokai J Exp Clin Med"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.gtc.2014.11.008","article-title":"Prokinetics in gastroparesis","volume":"44","author":"Acosta","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"issue":"7","key":"10.1016\/j.rdc.2017.09.002_bib72","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/1529-0131(199907)42:7<1545::AID-ANR30>3.0.CO;2-T","article-title":"Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue diseases","volume":"42","author":"Perlemuter","year":"1999","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.rdc.2017.09.002_bib73","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ14-0088","article-title":"Clinical effects of ghrelin on gastrointestinal involvement in patients with systemic sclerosis","volume":"61","author":"Ariyasu","year":"2014","journal-title":"Endocr J"},{"issue":"24","key":"10.1016\/j.rdc.2017.09.002_bib74","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.3748\/wjg.v16.i24.2978","article-title":"Small intestinal bacterial overgrowth syndrome","volume":"16","author":"Bures","year":"2010","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.rdc.2017.09.002_bib75","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/apt.12479","article-title":"Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth","volume":"38","author":"Shah","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.002_bib76","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/apt.13928","article-title":"Systematic review with meta-analysis: rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth","volume":"45","author":"Gatta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11926-011-0217-3","article-title":"Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management","volume":"14","author":"Gyger","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.rdc.2017.09.002_bib78","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MCG.0000000000000814","article-title":"Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence","volume":"51","author":"Zhong","year":"2017","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.rdc.2017.09.002_bib79","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cgh.2012.12.011","article-title":"Proton pump inhibitor use and the risk of small intestinal bacterial overgrowth: a meta-analysis","volume":"11","author":"Lo","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.rdc.2017.09.002_bib80","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.51.6.881","article-title":"Sacral nerve stimulation for faecal incontinence due to systemic sclerosis","volume":"51","author":"Kenefick","year":"2002","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib81","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00000658-200007000-00020","article-title":"Permanent sacral nerve stimulation for fecal incontinence","volume":"232","author":"Malouf","year":"2000","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.rdc.2017.09.002_bib82","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4166\/kjg.2012.59.1.48","article-title":"Liver cirrhosis due to autoimmune hepatitis combined with systemic sclerosis","volume":"59","author":"You","year":"2012","journal-title":"Korean J Gastroenterol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X1730073X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X1730073X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:16:56Z","timestamp":1760181416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X1730073X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S0889857X1730073X"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2017.09.002","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal and Hepatic Disease in Systemic Sclerosis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}